BM
bioMérieux S.A.
BMXMF · OTC
$83.27 +0.00% (+$0.00)
1M -4.16%
Market Cap 8.66B €
P/E Ratio 21.79x
Div. Yield 1.36%
ROE 9.62%
Bulios Fair Price
$48.35
41.9% downside
Current Price
$83.27
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BMXMF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
8/9Valuation
73 /100
Cheap P/FCF 19.12x
P/E 21.79x
P/B 2.11x
Growth
47 /100
Stable FCF growth 33.95%
EPS growth 4.38%
Book val. growth 4.39%
Profitability
71 /100
Strong Op. margin 13.79%
Gross margin 52.63%
FCF margin 11.13%
Quality
53 /100
Average ROA 7.13%
ROIC 9.13%
Asset turnover 0.73x
Debt
100 /100
Low Net debt/EBITDA -0.11x
Debt/Equity 0.11x
Current ratio 2.39x
Stability
93 /100
Stable EPS volatility 21.58%
Beta 0.57x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BMXMF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Pierre Boulud
Employees
15,078
Headquarters
Marcy l'Étoile
Upcoming events
04 MAR
Earnings
Upcoming earnings report